Amylopectinosis is a condition characterized by excessive accumulation of amylopectin in the liver.
糖原累积症是一种以肝脏中淀粉样蛋白积累为特征的病症。
The histological examination revealed signs of
amylopectinosis in the patient's pancreas.
组织学检查显示患者胰腺存在淀粉样蛋白病的迹象。
Symptoms of
amylopectinosis often include fatigue, abdominal pain, and jaundice.
淀粉样蛋白病的症状通常包括疲劳、腹痛和黄疸。
Diet modification is essential for managing the symptoms of
amylopectinosis in children.
对于儿童来说,调整饮食是控制淀粉样蛋白病症状的关键。
Early diagnosis of
amylopectinosis is crucial to prevent complications in severe cases.
早期诊断淀粉样蛋白病对于防止严重并发症至关重要。
Researchers found a correlation between genetic mutations and the development of
amylopectinosis.
研究人员发现基因突变与淀粉样蛋白病的发展有关联。
Treatment for
amylopectinosis often involves enzyme replacement therapy and close monitoring.
淀粉样蛋白病的治疗通常包括酶替代疗法以及密切观察。
In some cases,
amylopectinosis can lead to liver failure if left untreated.
若不治疗,淀粉样蛋白病可能导致肝功能衰竭。
The patient's response to treatment was promising, showing signs of improvement in
amylopectinosis.
患者的治疗反应良好,淀粉样蛋白病的状况有所改善。
Further studies are needed to fully understand the underlying mechanisms of
amylopectinosis progression.
进一步的研究对于完全理解淀粉样蛋白病进展的机制是必要的。
未经许可,严禁转发。QQ交流群:688169419